Back to search

Netherlands· NL-5694e59ffcce

Atacand 16, tabletten 16 mg

A candesartan product containing candesartancilexetil, registered in Netherlands by CHEPLAPHARM Arzneimittel GmbH. The same ATC class is registered in 16 of our 19 countries.

ATC C09CA06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAtacand 16, tabletten 16 mgATCC09CA06REGISTER NO.NL-5694e59ffccePACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Candesartan is registered in 16 of 19 countries.

Countries holding a registration under ATC C09CA06 (candesartan), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Candesartan · ATC C09CA06

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of candesartan costs, country by country.

Normalised to the WHO defined daily dose (8 mg), the median price runs from $0.15 in Italy to $0.36 in Switzerland — a ×2.3 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Candesartan · price per daily dose (8 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.36
  • ES Spain$0.21
  • IT Italy$0.15
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CANDESARTANCILEXETIL
Manufacturer
CHEPLAPHARM Arzneimittel GmbH
Country
Netherlands (NL)
ATC code
C09CA06
ATC class
Candesartan
Defined daily dose
8 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    21706

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for candesartan.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Candesartan · interactions on record

81 records

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/336cf193-3026-4589-bca9-e8804f63f489
GET /v1/drugs/336cf193-3026-4589-bca9-e8804f63f489?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h21706_smpc.pdf",
  "strength": null,
  "atc_label": "Candesartan",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg21706",
  "excipients": [
    "CARMELLOSE CALCIUM (E 466)",
    "HYPROLOSE (E 463)",
    "IJZEROXIDE ROOD-BRUIN (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 8000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL"
  ],
  "substances": [
    "CANDESARTANCILEXETIL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h21706.pdf",
  "authorised_at": "1997/10/13",
  "procedure_number": "SE/H/1865/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "21706",
  "additional_monitoring": "N"
}

See everything about candesartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.